Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
InfuMedics is a medical technology company specializing in the development of advanced implantable drug delivery systems, most notably the Prometra programmable infusion pump. The company's core technology features a patented dual-gated valve mechanism designed to provide high dosing accuracy and extended device longevity for intrathecal drug delivery. This system is primarily used for the targeted administration of medications like morphine and baclofen to treat chronic pain and severe spasticity. While the original InfuMedics was acquired by Arrow International in 1997, the technology and its subsequent iterations were further developed and commercialized through Flowonix Medical (now Infusyn Therapeutics), which was acquired by Algorithm Sciences in 2023. Today, the InfuMedics entity continues to be associated with the intellectual property and investment surrounding these precision drug delivery platforms.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on InfuMedics.